Additionally, we identified a novel mechanism involving GPCR heteromerization, providing an experimental foundation for developing anti-inflammatory and reparative therapies targeting the A2aR–mGluR5 heteromer in CCH neuroinflammation. Here, GRM5 is linked to columnar cell hyperplasia of the breast.